Synairgen Plc (SNG.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 06-2004 | |
| Cash Flows From Operating Activities | |
| Accounts receivable | -77 |
| Other Working Capital | 86 |
| Other Operating Activity | -74 |
| Operating Cash Flow | $-65 |
| Cash Flows From Investing Activities | |
| PPE Investments | -151 |
| Investing Cash Flow | $-151 |
| Cash Flows From Financing Activities | |
| Common Stock Issued | 1 |
| Other Financing Activity | 622 |
| Financing Cash Flow | $623 |
| End Cash Position | 407 |
| Net Cash Flow | $407 |
| Free Cash Flow | |
| Operating Cash Flow | -65 |
| Capital Expenditure | -151 |
| Free Cash Flow | -216 |